autoimmune inc (AIMM) Details

AutoImmune Inc., a development stage company, develops products for the treatment of autoimmune and other cell-mediated inflammatory diseases and conditions. It offers a dietary supplement under Colloral, The Collagen Solution, and Vital 3 brand names for treating the signs and symptoms of rheumatoid arthritis. The company’s products under development include MBP8298, which is in Phase III clinical trials for the treatment of secondary progressive multiple sclerosis, as well as in Phase II clinical trials for relapsing-remitting multiple sclerosis; Oral Copaxone that is in preclinical stage for the treatment of multiple sclerosis; and AI 401, which is in Phase III clinical trails for the treatment of Type I diabetes. AutoImmune has a joint venture with Deseret Laboratories, Inc. to manufacture, market, and sell Colloral as a dietary supplement. It also has collaboration agreements with The Brigham and Women’s Hospital and Eli Lilly and Company. The company was formerly AutoImmune Technologies, Inc. and changed its name to AutoImmune Inc. in July 1991. AutoImmune was founded in 1988 and is based in Pasadena, California.

autoimmune inc (AIMM) Top Compensated Officers